Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reck

Showing results (11-20 of 1,722) with videos related to

Pageof 173
Sort By:
Expert Review of Anticancer Therapy|June 18, 2010
A major step towards individualized therapy of lung cancer with gefitinib: the IPASS trial and beyondMartin Reck
Schmerz (Berlin, Germany)|June 12, 2003
[The placebo trap]R Reck
Der Radiologe|August 1, 1984
[Headaches caused by ENT diseases]R Reck
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?M Reck
Zeitschrift Fur Medizinische Labortechnik|January 1, 1974
[Method for the determination of isoenzymes of alkaline phosphatase]R Reck
Expert Review of Anticancer Therapy|April 2, 2015
Nintedanib: examining the development and mechanism of action of a novel triple angiokinase inhibitorMartin Reck
Targeted Oncology|September 16, 2010
Examining the safety profile of angiogenesis inhibitors: implications for clinical practiceMartin Reck
Laryngologie, Rhinologie, Otologie|September 1, 1986
[Spontaneous thyroid gland hemorrhage as a cause of acute laryngostenosis]R Reck
Schmerz (Berlin, Germany)|March 25, 2004
[Victory for the pain patient--a pyrrhic victory? Response to the editorial by P. Knuth in Schmerz 3/97]Reck R
Versicherungsmedizin|January 6, 2006
[Chronic back pain and expert opinion]R Reck
Pageof 173

Showing results (11-20 of 1,722) with videos related to

Sort By:
Pageof 173
Expert Review of Anticancer Therapy|June 18, 2010
A major step towards individualized therapy of lung cancer with gefitinib: the IPASS trial and beyondMartin Reck
Schmerz (Berlin, Germany)|June 12, 2003
[The placebo trap]R Reck
Der Radiologe|August 1, 1984
[Headaches caused by ENT diseases]R Reck
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?M Reck
Zeitschrift Fur Medizinische Labortechnik|January 1, 1974
[Method for the determination of isoenzymes of alkaline phosphatase]R Reck
Expert Review of Anticancer Therapy|April 2, 2015
Nintedanib: examining the development and mechanism of action of a novel triple angiokinase inhibitorMartin Reck
Targeted Oncology|September 16, 2010
Examining the safety profile of angiogenesis inhibitors: implications for clinical practiceMartin Reck
Laryngologie, Rhinologie, Otologie|September 1, 1986
[Spontaneous thyroid gland hemorrhage as a cause of acute laryngostenosis]R Reck
Schmerz (Berlin, Germany)|March 25, 2004
[Victory for the pain patient--a pyrrhic victory? Response to the editorial by P. Knuth in Schmerz 3/97]Reck R
Versicherungsmedizin|January 6, 2006
[Chronic back pain and expert opinion]R Reck
Pageof 173